AT193 / Azora Therap - LARVOL DELTA

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa (clinicaltrials.gov) - P1 | N=49 | Completed | Sponsor: Azora Therapeutics Australia Pty Ltd | Active, not recruiting ➔ Completed | Phase classification: P1b ➔ P1

Phase classification • Trial completion • Dermatology • Hidradenitis Suppurativa • Immunology

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa (clinicaltrials.gov) - P1b | N=44 | Active, not recruiting | Sponsor: Azora Therapeutics Australia Pty Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • Dermatology • Hidradenitis Suppurativa

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis (clinicaltrials.gov) - P1b | N=34 | Active, not recruiting | Sponsor: Azora Therapeutics Australia Pty Ltd | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2022 ➔ Aug 2023 | Trial primary completion date: Dec 2022 ➔ Aug 2023

Enrollment closed • Trial completion date • Trial primary completion date • Dermatology • Immunology • Psoriasis • Psoriatic Arthritis

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa (clinicaltrials.gov) - P1b | N=44 | Recruiting | Sponsor: Azora Therapeutics Australia Pty Ltd | Trial completion date: Jun 2022 ➔ Feb 2023 | Trial primary completion date: Jun 2022 ➔ Feb 2023

Trial completion date • Trial primary completion date • Dermatology • Hidradenitis Suppurativa

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis (clinicaltrials.gov) - P1b; N=34; Recruiting; Sponsor: Azora Therapeutics Australia Pty Ltd; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Dermatology • Immunology • Psoriasis • Psoriatic Arthritis

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis (clinicaltrials.gov) - P1b; N=30; Not yet recruiting; Sponsor: Azora Therapeutics Australia Pty Ltd

Clinical • New P1 trial • Dermatology • Immunology • Psoriasis • Psoriatic Arthritis